Hessemer V, Frohloff H, Eisenmann D, Jacobi K W
Universitäts-Augenklinik Giessen.
Ophthalmologe. 1994 Aug;91(4):465-8.
The mesopic visual acuity (MVA) after intraocular lens (IOL) implantation is reduced compared to phakic patients of the same age. However, previous studies from our clinic have shown no significant MVA difference between multi- and monofocal IOLs. In the present study (with the patients matched exactly for age), this topic was reevaluated.
We investigated three groups, each consisting of 28 persons, 51 to 60 years of age. Group I consisted of healthy phakic volunteers, group II of patients 3 months after cataract extraction and implantation of a monofocal posterior chamber IOL (Pharmacia 720A) and group III of patients 3 months after implantation of a diffractive multifocal posterior chamber IOL with biconvex optic configuration (3M 825X). The MVA was examined using the "Ocutrast," described by Nowak. The Ocutrast, a modification of the Mesoptometer II, provides a field luminance of 1 cd/m2 and a contrast of 1:23 between test optotype and background; the intensity of illumination under glare conditions amounts to 0.35 lx at the level of the pupil.
The MVA without glare amounted to 0.50 +/- 0.12 (group I, healthy phakic eyes), 0.45 +/- 0.15 (group II, monofocal IOLs) and 0.32 +/- 0.11 (group III, multifocal IOLs). The MVA with glare amounted to 0.47 +/- 0.08 (group I), 0.35 +/- 0.12 (group II) and 0.24 +/- 0.10 (group III). Both for the MVA with and without glare there was a significant group difference (P < 0.05; two-factor analysis of covariance with repeated measurements).
After implantation of diffractive multifocal IOLs of the presently used type (3M 825X), the mesopic vision--both with and without glare--is even more reduced than after monofocal IOL implantation. These findings are particularly relevant for aged pseudophakic car drivers, especially for driving at night.
与同龄有晶状体眼患者相比,人工晶状体(IOL)植入术后的中间视觉视力(MVA)有所降低。然而,我们诊所之前的研究表明,多焦点和单焦点IOL之间的MVA没有显著差异。在本研究中(患者年龄完全匹配),对该主题进行了重新评估。
我们调查了三组,每组28人,年龄在51至60岁之间。第一组由健康的有晶状体眼志愿者组成,第二组由白内障摘除并植入单焦点后房型IOL(Pharmacia 720A)3个月后的患者组成,第三组由植入双凸光学结构的衍射多焦点后房型IOL(3M 825X)3个月后的患者组成。使用Nowak描述的“Ocutrast”检查MVA。Ocutrast是Mesoptometer II的一种改进型,提供1 cd/m2的视野亮度以及测试视标与背景之间1:23的对比度;眩光条件下瞳孔水平的照明强度为0.35 lx。
无眩光时的MVA为0.50±0.12(第一组,健康有晶状体眼)、0.45±0.15(第二组,单焦点IOL)和0.32±0.11(第三组,多焦点IOL)。有眩光时的MVA为0.47±0.08(第一组)、0.35±0.12(第二组)和0.24±0.10(第三组)。无论有无眩光,MVA在组间均存在显著差异(P<0.05;重复测量的双因素协方差分析)。
植入目前使用类型(3M 825X)的衍射多焦点IOL后,无论有无眩光,中间视觉均比植入单焦点IOL后下降得更明显。这些发现对于老年人工晶状体眼汽车驾驶员尤其重要,尤其是在夜间驾驶时。